[Use of L-asparaginase in therapy with special reference to acute lymphatic leukemia].
D000293:Adolescent; D000328:Adult; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy; D001791:Blood Platelet Disorders / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D005260:Female; D005334:Fever / Q000139:chemically induced; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone
Il punto sull'impiego della L-asparaginasi in terapia con particolar riguardo alla leucemia linfatica acuta.